Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic CancerRoberto Alva‐Ruiz, Mark J. Truty, Amit Mahipal et al.|Annals of Surgical Oncology|2021Cited by 68
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic AdenocarcinomaAmro M. Abdelrahman, Mark J. Truty, Ajit H. Goenka et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 59
Re-resection of Microscopically Positive Margins Found on Intraoperative Frozen Section Analysis Does Not Result in a Survival Benefit in Patients Undergoing Surgery and Intraoperative Radiation Therapy for Locally Recurrent Rectal CancerJames Ansell, Eric J. Dozois, William Perry et al.|Diseases of the Colon & Rectum|2021Cited by 6